Business Trends

Oct 11, 2017
By BioPharm International Editors
The company is considering options for a full or partial separation of its Consumer Healthcare business, either through a spin-off, sale, or other transaction.
Oct 01, 2017
BioPharm International
Reeling from financial and tropical storms, Puerto Rico needs stable industry to aid its recovery.
Sep 15, 2017
BioPharm International
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.
Sep 01, 2017
BioPharm International
Faced with divisive political and social issues, Congress must find a way to reach consensus.
Jul 01, 2017
BioPharm International
How has the bio/pharmaceutical contract manufacturing industry evolved and changed over the years and what does the future hold?
Jul 01, 2017
BioPharm International
CDER’s Janet Woodcock endorses modern drug manufacturing to ensure access to safe and reliable medicines.
Jul 01, 2017
BioPharm International
New reports address biopharma’s leading concerns: funding for drug development and pricing of finished drugs.
Jun 27, 2017
By BioPharm International Editors
Drug sales forecasts fall for first time in 10 years, thanks to pressures to reduce drug prices and the advent of biosimilars.
Jun 27, 2017
By BioPharm International Editors
BIO report measures decade-long investment and acquisition trends for emerging biotech companies.
Jun 01, 2017
BioPharm International
New reports indicate that drug prices are slowing compared to other healthcare costs.
native1_300x100
lorem ipsum